1229 results found.
                    
Anika Gains Australia Approval for MONOVISC Viscosupplement
Anika Therapeutics received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for t...
OrthoPediatrics Closes IPO at $59.8 Million
OrthoPediatrics closed its IPO, raising gross proceeds of US $59.8MM.
Surgical Specialties to Distribute Ortho-ATI in Australia, New Zealand
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand
Vivorte Launches New Bone Graft Products
Vivorté launched FORTERA™ and REGENTO™ bone graft products for orthopaedic surgery.
Musculoskeletal Transplant Foundation Rebrands as MTF Biologics
Musculoskeletal Transplant Foundation changed its name to MTF Biologics.
FDA Allows IND for DiscGenics' Clinical Study
FDA accepted DiscGenics' Investigational New Drug Application for a clinical study of its cell therapy product candidate to treat degenerati...
DiscGenics Raises $14 Million for Injectable Cell Therapy
DiscGenics closed a US $14MM Series B financing. Funds will support regulatory approvals and manufacturing ramp-u...
HCT Regenerative to Distribute LifeLink Allografts in Taiwan
LifeLink Tissue Bank will provide allografts to treat sports, orthopaedic and spine injuries to HCT Regener...
Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB
Bone Therapeutics signed an exclusive license agreement with Asahi Kasei to develop and commercialize PR...
SpinalCyte Receives Australian Patent for Cartilage Repair
SpinalCyte was issued Australian Patent No. 2015202319, “Methods and Compositions for Repair of Cartilage Using a...
Bone Therapeutics ALLOB Phase I/IIA Delayed-Union Fracture Trial Update
Bone Therapeutics reports positive interim efficacy results and early conclusion of the Phase I/IIA study...
Bone Solutions Launches OsteoCrete Magnesium-Based Bone Void Filler
Bone Solutions commenced U.S. launch of OsteoCrete®, the first magnesium-based bone void filler
Artoss Enters DAPA Agreement for NanoBone Graft Products
Artoss entered into a Defense Acquisition Purchasing Agreement with Owens & Minor for U.S. Department of Defense...
Interim Results in ALLOB Phase IIA Spinal Fusion Study
Interim results in a Phase IIA trial with Bone Therapeutics' ALLOB® show evidence of successful spinal fusion
Cerapedics 2-Year Follow-Up Data on i-FACTOR Bone Graft in the Cervical Spine
Follow-up data from an IDE clinical trial of Cerapedics' i-FACTOR™ bone graft indicated statistica...
MiMedx Can Launch Phase 3 IND Trial for Achilles Tendonitis
MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® ...
Centric Medical Posts 112% Growth Within Foot & Ankle
Centric Medical announced record revenue growth of TARSA-LINK™ Stand-Alone Wedge Fixation, ...
CollPlant Negotiating Private Placement of $5MM
CollPlant is in advanced negotiations with a U.S. investor for a US $5.0MM private placement.
Orthocell Recruits First Patient for Ortho-ATI Shoulder Tendon Study
Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI
Bioventus Receives FDA Premarket Approval for DUROLANE
Bioventus received FDA premarket approval for DUROLANE single-injection hyaluronic acid to treat pain associated with
Medtronic Launches Study of INFUSE in PLF and TLIF
Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in
Kuros Biosciences Receives Additional FDA 510(k) Clearance for MagnetOs Putty
Kuros Biosciences received FDA 510(k) clearance to market MagnetOs synthetic bone graft putty as an auto...
Medtronic Posts FY1Q18 Revenue Growth
ORTHOWORLD estimates Medtronic’s FY1Q18 revenue at US $728.0MM, +1.0% vs. FY1Q17. (Quarter ended 7/28/17) 
Regentis Biomaterials Receives CE Mark Approval for GelrinC Implant
Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured ...
Bone Biologics Expands Relationship with UCLA
Bone Biologics entered into an exclusive license agreement with UCLA for global application of NELL-1 protein in t...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group